Melatonin Research
Product image coming soon
Melatonin: Circadian Biology and MT1/MT2 Receptor Research
Melatonin (N-acetyl-5-methoxytryptamine) is a naturally occurring indoleamine hormone synthesised primarily by the pineal gland from serotonin. It is studied in laboratory settings for its role in circadian rhythm regulation, MT1/MT2 receptor pharmacology, antioxidant signalling, and immune modulation research.
Melatonin: Structure and Receptor Pharmacology
Chemical and Molecular Data
| Property | Value |
|---|---|
| Molecular formula | C13H16N2O2 |
| Molecular weight | 232.28 g/mol |
| CAS number | 73-31-4 |
| Chemical name | N-acetyl-5-methoxytryptamine |
| Chemical class | Indoleamine |
| Purity | greater than or equal to 98% as verified by HPLC |
| Form | Lyophilised powder |
| Storage | -20 degrees C, protected from light and moisture |
| Reconstitution | DMSO or ethanol recommended |
Melatonin: Structure and Receptor Pharmacology
Biosynthesis and Structural Chemistry
Melatonin is synthesised from tryptophan via serotonin in a two-step enzymatic process: arylalkylamine N-acetyltransferase (AANAT) converts serotonin to N-acetylserotonin, which hydroxyindole-O-methyltransferase (HIOMT) then methylates to produce melatonin. The indole core with methoxy group at position 5 and N-acetyl at position 1 defines the pharmacophore for MT1/MT2 receptor binding.
MT1 and MT2 Receptor Pharmacology
Melatonin exerts its primary circadian regulatory effects through two G-protein coupled receptors: MT1 (MTNR1A) and MT2 (MTNR1B). Both are Gi-coupled GPCRs whose activation reduces cAMP production via inhibition of adenylyl cyclase.
MT1 receptor. Research has examined MT1-mediated effects on neuronal firing in the suprachiasmatic nucleus (SCN), the master circadian pacemaker. MT1 activation is studied in the context of circadian phase shifting and sleep-wake cycle regulation.
MT2 receptor. MT2 activation has been studied in the context of circadian phase shifting at a different time window from MT1, and also in retinal physiology and glucose metabolism. MT2 variants have been examined in the context of type 2 diabetes susceptibility in genetic studies.
Antioxidant Research
Melatonin has been studied as a direct free radical scavenger and indirect antioxidant. Unlike classical antioxidants, melatonin does not undergo redox cycling after neutralising reactive species — it follows a cascade reaction generating several metabolites (AFMK, AMK) that are also studied for antioxidant activity. Research has examined melatonin's effects on mitochondrial ROS production and its interactions with the mitochondrial permeability transition pore — connecting it to SS-31 research in mitochondrial oxidative stress biology.
Immune and Anti-inflammatory Research
Laboratory studies have examined melatonin's effects on cytokine expression in immune cell models, NF-kB pathway activity, and NLRP3 inflammasome activation. Research has investigated melatonin's role as an immunomodulatory molecule relevant to inflammatory signalling research.
Melatonin vs Synthetic Receptor Agonists
| Compound | MT1 | MT2 | Selectivity | Half-life |
|---|---|---|---|---|
| Melatonin | Agonist | Agonist | Non-selective | ~45 min |
| Ramelteon | Agonist | Agonist | MT1/MT2 > MT3 | ~1-2.6 hr |
| Agomelatine | Agonist | Agonist | MT1/MT2 | ~1-2 hr |
| Tasimelteon | Agonist | Agonist | MT1/MT2 | ~1-1.3 hr |
Circadian Biology: The Suprachiasmatic Nucleus
The suprachiasmatic nucleus (SCN) of the hypothalamus is the master circadian pacemaker in mammals. SCN neurons express circadian clock genes (CLOCK, BMAL1, PER1/2/3, CRY1/2) that generate autonomous 24-hour oscillations through transcription-translation feedback loops. Melatonin acts on SCN neurons via MT1 and MT2 receptors to phase-shift these molecular oscillations.
Key melatonin-SCN research areas include:
- MT1-mediated acute suppression of SCN firing rate — studied in electrophysiology models of hypothalamic slices
- MT2-mediated phase shifting — examined in circadian phase-response curve experiments
- Light-melatonin interaction — light suppresses melatonin synthesis via the retinohypothalamic tract; research models examine how light exposure timing affects melatonin-mediated circadian entrainment
- Temperature entrainment — melatonin influences peripheral circadian oscillators partly via thermoregulation
Frequently Asked Questions
Why is melatonin classified as both a hormone and an antioxidant in research?
Melatonin fulfils the classical definition of a hormone: it is synthesised in a specific gland (pineal), released into the circulation, and acts on distant target cells via receptors. However, it also functions as a direct free radical scavenger independently of receptors — it reacts with hydroxyl radicals, superoxide, and other reactive species through electron transfer reactions. The antioxidant cascade is receptor-independent and has been studied in cell-free and cell-based oxidative stress models. This dual functionality (receptor-dependent circadian regulation and receptor-independent antioxidant activity) makes Melatonin unusual among hormones as a research compound.
How does melatonin reach mitochondria?
Melatonin is lipophilic and can cross all biological membranes without requiring transport proteins, including the inner mitochondrial membrane. Research has found that melatonin concentrations in mitochondria may be substantially higher than plasma concentrations, and mitochondria may even synthesise some melatonin independently of the pineal gland. This mitochondrial accumulation connects Melatonin research to the mitochondrial biology studied with SS-31 and MOTS-c.
Published Research References
For laboratory and analytical research purposes only. Not for human or veterinary use. No dosage or administration guidance is provided or implied.
